127 related articles for article (PubMed ID: 15678388)
1. [Oncogenic osteomalacia in a 49-year-old female patient].
Ludwig J; Mechtersheimer G; Haberkorn U; Nawroth P; Schilling T; Kasperk C
Dtsch Med Wochenschr; 2005 Feb; 130(5):206-9. PubMed ID: 15678388
[TBL] [Abstract][Full Text] [Related]
2. Tumour-induced osteomalacia: a literature review and a case report.
Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
[TBL] [Abstract][Full Text] [Related]
3. [Oncogenic hypophosphatemic osteomalacia].
Schultze G; Delling G; Faensen M; Haubold R; Loy V; Molzahn M; Pommer W; Semler J; Trempenau B
Dtsch Med Wochenschr; 1989 Jul; 114(27):1073-8. PubMed ID: 2737097
[TBL] [Abstract][Full Text] [Related]
4. [Hypophosphatemic oncogenic osteomalacia].
Mátyus J; Szebenyi B; Rédl P; Mikita J; Gáspár L; Haris A; Radó J; Kakuk G
Orv Hetil; 2000 Dec; 141(51):2785-8. PubMed ID: 11196239
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
Seijas R; Ares O; Sierra J; Pérez-Dominguez M
Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
[TBL] [Abstract][Full Text] [Related]
6. Bone densitometry in a patient with hypophosphatemic osteomalacia.
Negri AL; Bogado CE; Zanchetta JR
J Bone Miner Metab; 2004; 22(5):514-7. PubMed ID: 15316875
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
[TBL] [Abstract][Full Text] [Related]
8. [Hypophosphatemic osteomalacia in adults].
Löhr-Schwaab S; Wanner C; Reinbold WD; Schümichen C; Schölmerich J; Schaefer HE; Gerok W
Dtsch Med Wochenschr; 1989 Apr; 114(14):538-42. PubMed ID: 2702931
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.
Rhee Y; Lee JD; Shin KH; Lee HC; Huh KB; Lim SK
Clin Endocrinol (Oxf); 2001 Apr; 54(4):551-4. PubMed ID: 11318793
[TBL] [Abstract][Full Text] [Related]
11. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
Huang QL; Feig DS; Blackstein ME
J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic osteomalacia cured by removal of an organized hematoma.
Colt E; Gopan T; Chong HS
Endocr Pract; 2005; 11(3):190-3. PubMed ID: 16239206
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic osteomalacia should be considered in hypophosphatemia, bone pain and pathological fractures.
Kaniuka-Jakubowska S; Biernat W; Lewczuk A; Świątkowska-Stodulska R; Sworczak K
Endokrynol Pol; 2012; 63(3):234-8. PubMed ID: 22744630
[TBL] [Abstract][Full Text] [Related]
14. Phosphaturic mesenchymal tumor, mixed connective tissue variant (oncogenic osteomalacia).
Tsujimura T; Sakaguchi K; Aozasa K
Pathol Int; 1996 Mar; 46(3):238-41. PubMed ID: 10846577
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.
Sato K; Obara T; Yamazaki K; Kanbe M; Nakajima K; Yamada A; Yanagisawa T; Kato Y; Nishikawa T; Takano K
J Clin Endocrinol Metab; 2001 Nov; 86(11):5564-71. PubMed ID: 11701736
[TBL] [Abstract][Full Text] [Related]
16. [Hypophosphatemic osteomalacia].
Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
[TBL] [Abstract][Full Text] [Related]
17. Case report. Tumour-induced osteomalacia in a patient with osseous haemangioma.
Lui CY; Khoo R; Law TC; Chong SF
Clin Radiol; 2002 Dec; 57(12):1125-7. PubMed ID: 12475540
[No Abstract] [Full Text] [Related]
18. Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery.
Harbeck B; Schöcklmann H; Seekamp A; Czech N; Mönig H
J Clin Rheumatol; 2009 Feb; 15(1):31-4. PubMed ID: 19125132
[TBL] [Abstract][Full Text] [Related]
19. [Oncogenic osteomalacia: its pathogenesis, clinical picture and treatment].
Ermolenko VM; Melikaian AM; Shotemor ShSh; Potapova AV
Ter Arkh; 1995; 67(5):58-61. PubMed ID: 7638783
[TBL] [Abstract][Full Text] [Related]
20. Iatrogenic osteomalacia and myopathy due to phosphate depletion.
Baker LR; Ackrill P; Cattell WR; Stamp TC; Watson L
Br Med J; 1974 Jul; 3(5924):150-2. PubMed ID: 4843652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
